Backed by its new products and pipeline drugs, AstraZeneca believes it can post industry-leading ... You can see the complete ...

Apollo Tyres, Thermax, PI Industries, Deepak Nitrite, Bayer CropScience, Brigade Enterprises, NBCC (India), Wockhardt, ...

Good day and thank you for standing by. Welcome to the Absci Q3 2024 Business Update Conference Call. At this time, all ...

This collaboration combines Absci's integrated drug creation platform with Astrazeneca's expertise in oncology ... we are pleased to be adding another new partner to our diverse list of collaborators ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

The Company applies its proprietary uSMITEtm (ubiquitin-mediated, small molecule-induced target elimination) platform to expand the drug design paradigm beyond ... Works with Glance is a Qualified ...

If you have not received this news release or you'd like to be added to the company's e-mail distribution list, please subscribe to our e-mail ... transport system to selectively deliver anticancer ...

Other notable companies announcing earnings on Wednesday include Kalyan Jewellers, Garden Reach Shipbuilders, Vodafone Idea, ...

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

Andrew Berens gave his rating based on several factors, including AstraZeneca’s strong financial performance in the third quarter of 2024. The company reported total revenues of $13.565 billion, ...